...
首页> 外文期刊>Neuropharmacology >Mitochondria autophagy is induced after hypoxic/ischemic stress in a Drp1 dependent manner: The role of inhibition of Drp1 in ischemic brain damage
【24h】

Mitochondria autophagy is induced after hypoxic/ischemic stress in a Drp1 dependent manner: The role of inhibition of Drp1 in ischemic brain damage

机译:缺氧/缺血应激后以Drp1依赖性方式诱导线粒体自噬:抑制Drp1在缺血性脑损伤中的作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mitochondria dysfunction is implicated in diverse conditions, including metabolic and neurodegenera-tive disorders. Mitochondrial dynamics has attracted increasing attention as to its relationship with mitochondria autophagy, also known as mitophagy, which is critical for degradation of dysfunctional mitochondria maintaining mitochondrial homeostasis. Mitochondrial fission and its role in clearance of injured mitochondria in acute ischemic injury, however, have not been elucidated yet. Here we showed that hypoxic/ischemic conditions led to fragmentation of mitochondria and induction of mitophagy in permanent middle cerebral artery occlusion (pMCAO) rats and oxygen-glucose deprivation (OGD) PC12 cells. Inhibition of Drpl by pharmacologic inhibitor or siRNA resulted in accumulation of damaged mitochondria mainly through selectively blocking mitophagy without affecting mitochondrial biogenesis and non-selective autophagy. Drpl inhibitors increased the infarct volume and aggravated the neurological deficits in a rat model of pMCAO. We demonstrated that the devastating role of disturbed mitochondrial fission by inhibiting Drpl contributed to the damaged mitochondria-mediated injury such as ROS generation, cyt-c release and activation of caspase-3. Taken together, we proved that under hypoxic/ischemic stress a Drp1-dependent mitophagy was triggered which was involved in the removal of damaged mitochondria and cellular survival at the early stage of hypoxic/ischemic injury. Thus, Drpl related pathway involved in selective removal of dysfunctional mitochondria is proposed as an efficient target for treatment of cerebral ischemia.
机译:线粒体功能障碍与多种疾病有关,包括代谢和神经退行性疾病。线粒体动力学与线粒体自噬(也称为线粒体自噬)的关系已引起越来越多的关注,线粒体自噬对于功能异常的线粒体的降解至关重要,维持线粒体的体内稳态。线粒体分裂及其在急性缺血性损伤中清除线粒体的作用尚未阐明。在这里,我们显示缺氧/缺血性条件导致永久性大脑中动脉阻塞(pMCAO)大鼠和氧葡萄糖剥夺(OGD)PC12细胞的线粒体断裂和线粒体诱导。药理抑制剂或siRNA对Drpl的抑制作用主要是通过选择性阻断线粒体而不影响线粒体的生物发生和非选择性自噬,导致线粒体受损。在pMCAO大鼠模型中,Drp1抑制剂增加了梗塞体积并加重了神经功能缺损。我们证明了通过抑制Drpl干扰线粒体裂变的破坏性作用导致了受损的线粒体介导的损伤,如ROS生成,cyt-c释放和caspase-3活化。两者合计,我们证明了在缺氧/缺血应激下,Drp1依赖性线粒体被触发,这参与了缺氧/缺血损伤早期线粒体的清除和细胞存活。因此,涉及选择性去除功能异常的线粒体的Drpl相关途径被提议作为治疗脑缺血的有效靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号